Drug Shortage Report for DUVOID
| Report ID | 217075 |
| Drug Identification Number | 01947923 |
| Brand name | DUVOID |
| Common or Proper name | BETHANECHOL CHLORIDE |
| Company Name | PALADIN LABS INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | BETHANECHOL CHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 Tab |
| Anatomical Therapeutical Chemical (ATC) code | N07AB |
| Anatomical Therapeutical Chemical (ATC) description | PARASYMPATHOMIMETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-11 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-01-24 | French | Compare |
| v1 | 2024-01-24 | English | Compare |
Showing 1 to 2 of 2